Author

Ting-Hao Kuo

European Molecular Biology LaboratoryORCID 0000-0001-5130-0570Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:metabolomics· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1

Frequent Co-Authors

Adetunji T. ToriolaiD· 1 shared Alexander BrobeiliD· 1 shared Amber Brauer-NikonowiD· 1 shared Annalen BleckmanniD· 1 shared Anoop SinghiD· 1 shared Bastian SeelbinderiD· 1 shared Biljana GigiciD· 1 shared Christina E. ZielinskiiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Adetunji T. ToriolaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintMar 23, 2026

Metabolic specialization structures gut bacterial niches and drives colorectal cancer progression

Lin-Lin Xu, Bastian Seelbinder, Zhengyuan Zhou…·Gianni Panagiotou

This study identifies Leptotrichia wadei as a pro-tumorigenic bacterium in CRC by linking metabolic specialization to microbial niches and tumor progression.

DOI 10.64898/2026.03.21.712571

humanmetagenomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintDec 9, 2025

Gut bacteria generate prodrugs in situ increasing systemic drug exposure

Ting-Hao Kuo, Anoop Singh, Amber Brauer-Nikonow…·Michael Zimmermann

The paper identifies gut bacteria that convert drugs into prodrugs, increasing systemic drug exposure and altering pharmacokinetics.

DOI 10.64898/2025.12.09.692405

humanmetabolomics

𝕏 PostBluesky